Senior insider sale
SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$7.72M
100K shares
What this filing means
HENDERSON MICHAEL THOMAS plans to sell 100K shares of SPYRE THERAPEUTICS, INC. valued at approximately $7.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/22/2026ACC: 0001950047-26-006375
Director
Since Jun 2023
100K
Shares to sell
$7.72M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/28/2024
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/28/2024 | Restricted Stock Units N/A | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
80K
Market value
$5.95M
5/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$1.77M
6/22/2026
Total
Units
100K
Value
$7.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/8/2026 | 80K | $5.95M | — | Completed |
| Planned — Approximate Date | ||||
6/22/2026 | 20K | $1.77M | NASDAQ | Planned |
| Total | 100K | $7.72M | ||